These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 24146399)

  • 1. Identification of ideal peptides for heterovalent ligands.
    Shrivastava A; von Wronski M; Tweedle MF; Nunn AD
    Methods Mol Biol; 2014; 1088():97-105. PubMed ID: 24146399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designer peptides: learning from nature.
    Shrivastava A; Nunn AD; Tweedle MF
    Curr Pharm Des; 2009; 15(6):675-81. PubMed ID: 19199988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A flexible method for preparation of peptide homo- and heterodimers functionalized with affinity probes, chelating ligands, and latent conjugating groups.
    Pillai R; Marinelli ER; Swenson RE
    Biopolymers; 2006; 84(6):576-85. PubMed ID: 16845666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From combinatorial chemistry to cancer-targeting peptides.
    Aina OH; Liu R; Sutcliffe JL; Marik J; Pan CX; Lam KS
    Mol Pharm; 2007; 4(5):631-51. PubMed ID: 17880166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly selective cyclic peptide ligands for NeutrAvidin and avidin identified by phage display.
    Meyer SC; Gaj T; Ghosh I
    Chem Biol Drug Des; 2006 Jul; 68(1):3-10. PubMed ID: 16923020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient isolation of peptide ligands for the endothelial cell protein C receptor (EPCR) using candidate receptor phage display biopanning.
    White SJ; Simmonds RE; Lane DA; Baker AH
    Peptides; 2005 Jul; 26(7):1264-9. PubMed ID: 15949645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a fusiogenic peptide GALA for intracellular delivery.
    Nakase I; Kogure K; Harashima H; Futaki S
    Methods Mol Biol; 2011; 683():525-33. PubMed ID: 21053154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avidin-biotin interaction mediated peptide assemblies as efficient gene delivery vectors for cancer therapy.
    Qu W; Chen WH; Kuang Y; Zeng X; Cheng SX; Zhou X; Zhuo RX; Zhang XZ
    Mol Pharm; 2013 Jan; 10(1):261-9. PubMed ID: 23146022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the affinity of SEB-binding peptides by repeating their sequence.
    Dudak FC; Kılıç N; Demir K; Yaşar F; Boyacı IH
    Biopolymers; 2012; 98(2):145-54. PubMed ID: 22733526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of structure in antibody cross-reactivity between peptides and folded proteins.
    Craig L; Sanschagrin PC; Rozek A; Lackie S; Kuhn LA; Scott JK
    J Mol Biol; 1998 Aug; 281(1):183-201. PubMed ID: 9680484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexed flow cytometry: high-throughput screening of single-chain antibodies.
    Ayriss J; Valero R; Bradbury AR; Pavlik P
    Methods Mol Biol; 2009; 525():241-60, xiii. PubMed ID: 19252858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotinylated bionanocapsules for displaying diverse ligands toward cell-specific delivery.
    Shishido T; Azumi Y; Nakanishi T; Umetsu M; Tanaka T; Ogino C; Fukuda H; Kondo A
    J Biochem; 2009 Dec; 146(6):867-74. PubMed ID: 19710034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of avidin and streptavidin binding motifs among peptides selected from a synthetic peptide library consisting solely of D-amino acids.
    Gissel B; Jensen MR; Gregorius K; Elsner HI; Svendsen I; Mouritsen S
    J Pept Sci; 1995; 1(4):217-26. PubMed ID: 9222999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic cancer targeting peptides.
    Aina OH; Sroka TC; Chen ML; Lam KS
    Biopolymers; 2002; 66(3):184-99. PubMed ID: 12385037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
    Hou T; McLaughlin W; Lu B; Chen K; Wang W
    J Proteome Res; 2006 Jan; 5(1):32-43. PubMed ID: 16396493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and application of peptide-binding peptides.
    Zhang Z; Zhu W; Kodadek T
    Nat Biotechnol; 2000 Jan; 18(1):71-4. PubMed ID: 10625395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of affibody molecules for therapy and diagnostics.
    Feldwisch J; Tolmachev V
    Methods Mol Biol; 2012; 899():103-26. PubMed ID: 22735949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of the MHC class II molecules on B cells by peptide ligands.
    Agrawal B; Fraga E; Kane K; Singh B
    J Immunol; 1994 Feb; 152(3):965-75. PubMed ID: 8301149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic targeting of macromolecules using a pH-dependent fusogenic peptide in combination with cationic liposomes.
    Kobayashi S; Nakase I; Kawabata N; Yu HH; Pujals S; Imanishi M; Giralt E; Futaki S
    Bioconjug Chem; 2009 May; 20(5):953-9. PubMed ID: 19388672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.
    Campos SK; Barry MA
    Virology; 2006 Jun; 349(2):453-62. PubMed ID: 16504233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.